Mayne Pharma Group Limited

OTCPK:MAYN.F Stock Report

Market Cap: US$378.6m

Mayne Pharma Group Management

Management criteria checks 2/4

Mayne Pharma Group's CEO is Shawn O’Brien, appointed in Oct 2022, has a tenure of 1.5 years. total yearly compensation is A$1.50M, comprised of 44.2% salary and 55.8% bonuses, including company stock and options. directly owns 0.046% of the company’s shares, worth $172.81K. The average tenure of the management team and the board of directors is 2.3 years and 2.1 years respectively.

Key information

Shawn O’Brien

Chief executive officer

AU$1.5m

Total compensation

CEO salary percentage44.2%
CEO tenure1.5yrs
CEO ownership0.05%
Management average tenure2.3yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Shawn O’Brien's remuneration changed compared to Mayne Pharma Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$274m

Sep 30 2023n/an/a

-AU$296m

Jun 30 2023AU$2mAU$663k

-AU$317m

Compensation vs Market: Shawn's total compensation ($USD985.60K) is below average for companies of similar size in the US market ($USD2.37M).

Compensation vs Earnings: Insufficient data to compare Shawn's compensation with company performance.


CEO

Shawn O’Brien (64 yo)

1.5yrs

Tenure

AU$1,502,156

Compensation

Mr. Shawn Patrick O'Brien, B.Sc has been CEO, MD & Director at Mayne Pharma Group Limited since October 1, 2022. He serves as the Chief Commercial Advisor at Melanovus Oncology, Inc. Mr. O'Brien is a found...


Leadership Team

NamePositionTenureCompensationOwnership
Shawn O’Brien
CEO, MD & Director1.5yrsAU$1.50m0.046%
A$ 172.8k
Aaron Gray
Chief Financial Officer1.7yrsAU$1.30m0.016%
A$ 62.0k
Kimberly Parker
Executive VP & General Counsel2.3yrsno datano data
Brant Schofield
Executive Vice President of Corporate Development3.3yrsAU$1.29mno data
Erinn Nathaniel
Director of Global Human Resources1.3yrsno datano data
Daniel Moore
Executive Vice President of Commercial4.6yrsno datano data
Frank Casty
Executive VP & Global Chief Medical Officer1.3yrsno datano data
Brenton Walter
Financial Controller19.8yrsno datano data
Laura Loftus
Associate General Counsel & Company Secretary4.1yrsno datano data

2.3yrs

Average Tenure

Experienced Management: MAYN.F's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Shawn O’Brien
CEO, MD & Director1.5yrsAU$1.50m0.046%
A$ 172.8k
Frank Condella
Independent Non-Executive Chairman5.9yrsAU$297.04k0.081%
A$ 307.6k
Bruce Robinson
Independent Non-Executive Director9.7yrsAU$166.43k0.039%
A$ 148.1k
Patrick Blake
Independent Non-Executive Director5.8yrsAU$212.39k0.027%
A$ 103.1k
Ann Custin
Independent Non-Executive Director2.1yrsAU$212.39k0.026%
A$ 99.6k
Kathryn MacFarlane
Independent Non-Executive Director2.2yrsAU$212.42k0.047%
A$ 177.3k
Anne Lockwood
Directorless than a yearno datano data
David Petrie
Independent Non-Executive Director1.6yrsAU$137.96kno data

2.1yrs

Average Tenure

62yo

Average Age

Experienced Board: MAYN.F's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.